AdvaMed announced today that it has named Ashley McEvoy, EVP of MedTech at Johnson & Johnson, as its new chair. The group’s board of directors unanimously elected McEvoy as its chair during its quarterly meeting yesterday. She is the first woman to serve as chair at the major U.S. medical technology trade association, which was […]
Johnson & Johnson
Johnson & Johnson cuts nearly 350 surgical robotics jobs
Johnson & Johnson is letting go of nearly 350 employees in the surgical robotics space, according to layoff notices filed in California at the beginning of this month. The WARN notices list layoffs involving 292 workers at Auris, 47 at Verb Surgical, and four at Ethicon Endo-Surgery. All of the jobs were based in Santa […]
Biosense Webster marks first cases with dual energy ablation tech
Biosense Webster today announced the first cases with its investigational Thermocool SmartTouch SF dual energy catheter for treating AFib. The system enables doctors performing an ablation to toggle between two types of energy: pulsed-field and radiofrequency. It appears to be the Johnson & Johnson MedTech subsidiary’s answer to the dual energy ablation tech coming out […]
Johnson & Johnson is cutting jobs in its MedTech business
Johnson & Johnson announced restructuring and layoffs to employees over the past week that could eliminate at least 1,000 jobs, according to people inside and outside of the company. The reorganization included folding the company’s Mitek Sports Medicine business into another business, according to Rajit Kamal, the outgoing worldwide president of sports medicine and shoulder […]
FDA clears surgical robot from Noah Medical
Noah Medical announced that it received FDA clearance for its Galaxy System for robotic-navigated bronchoscopy. San Carlos, California-based Noah Medical designed Galaxy and its accessories to provide bronchoscopic visualization and access. These capabilities provide diagnostic and therapeutic procedures in patient airways. The system features advanced imaging technologies that provide real-time location updates for potentially cancerous […]
Supreme Court denies J&J appeal of $302M vaginal mesh ruling
The U.S. Supreme Court today declined to hear Johnson & Johnson‘s (NYSE:JNJ) appeal of a $302 million judgment for false and deceptive marketing of its vaginal mesh implants. The nation’s highest court denied the medtech maker’s bid for review without comment, allowing the California ruling to stand. Attorneys for the state sued Johnson & Johnson […]
Alcon to pay $199M to J&J to settle patent dispute
Alcon (SIX/NYSE: ALC) recently announced that it has settled a patent dispute with J&J Surgical Vision. The $199 million settlement, announced Feb. 12, ends a lawsuit that J&J had filed in June 2020 in U.S. District Court in Delaware. J&J Surgical Vision had claimed that Alcon femtosecond laser-assisted cataract surgery devices, including the company’s LenSx […]
J&J’s Ethicon completes first robot-assisted kidney stone removal with Monarch platform
Ethicon, a Johnson & Johnson MedTech company, today announced the first robotic-assisted removal of kidney stones using the Monarch platform. Auris Health, an Ethicon subsidiary, received FDA clearance for Monarch for endourological procedures in May 2022. The University of California, Irvine’s UCI Health used the Monarch platform for urology to complete the first procedure. According […]
Johnson & Johnson, 3M stocks down on ‘Texas two-step’ decision
Johnson & Johnson (NYSE:JNJ) stock dropped more than 3% in value today after a federal appeals court rejected its complex legal maneuver to shield itself from liability in talc-related lawsuits. 3M (NYSE: MMM) — which has also been seeking to do a “Texas two-step” to shield itself from liability in military earplug lawsuits — was […]
Johnson & Johnson reports mixed Q4 results amid shaky economy
Johnson & Johnson (NYSE:JNJ) today reported Q4 results that beat The Street on earnings but missed on revenue amid continued macroeconomic challenges. The company’s Pharmaceutical business saw sales grow 6.8%. Meanwhile, Johnson & Johnson MedTech — fresh off its $16.6 billion acquisition of Abiomed — was up 6.1%. Electrophysiology products in Interventional Solutions, contact lenses […]
DePuy Synthes to pay $9.75M to resolve surgeon kickbacks case
Johnson & Johnson’s DePuy Synthes has settled with federal prosecutors over allegations that it provided a Massachusetts-based surgeon with $100,000 worth of free products to win business. As part of the $9.75 million settlement agreement, DePuy Synthes admitted that it provided free cages, rods, screws, plates and modular access and retraction systems to the surgeon […]
